Home / Sensory organs / Timolol, Combinations
ATC S01ED51 · Ophthalmologicals
Timolol, Combinations shortage
As of 31 Oct 2026, Timolol, Combinations has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 22 products.
Countries5/5
Products22packs or presentations
Short since17 Jul 20233.3 years ago
Earliest return4 Nov 2026company estimate
No return date5products
Main reasonManufacturing problem
Timeline
GermanyItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Fixaprost 50 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis | Laboratoires Théa S.A.S. | 1 Aug 2026 | 1 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Fixaprost 50 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis | Laboratoires Théa S.A.S. | 1 Aug 2026 | 1 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| IT | LATANOPROST E TIMOLOLO ZENTIVA | ZENTIVA ITALIA S.R.L. | 17 Jul 2023 | not given | Increased demand Elevata richiesta |
| IT | EYROOBI | FIDIA FARMACEUTICI S.P.A. | 4 Jul 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | EQUITON | BRUSCHETTINI S.R.L. | 16 Mar 2026 | 1 Jun 2027 | Increased demand Elevata richiesta |
| IT | LATANOPROST E TIMOLOLO AUROBINDO ITALIA | AUROBINDO PHARMA (ITALIA) S.R.L. | 23 Mar 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | BIMATOPROST E TIMOLOLO TEVA | TEVA ITALIA S.R.L. | 28 Sep 2026 | 15 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | BRINZOLAMIDE E TIMOLOLO MYLAN | MYLAN S.P.A. | 19 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DORZOLAMIDE E TIMOLOLO PENSA announced | TOWA PHARMACEUTICAL S.P.A. | 16 Nov 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
| ES | COSDUO 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION 1 frasco de 5 ml | Santen Oy | 22 Jun 2025 | 31 Jan 2027 | Not stated |
| ES | FILIOP 40 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION 1 frasco de 2,5 ml | Horus Pharma | 20 Aug 2025 | 31 Dec 2026 | Not stated |
| ES | VIZILATAN DUO 50 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 2,5 ml | Bausch + Lomb Ireland Limited | 4 Mar 2026 | not given | Not stated |
| ES | DORZOLAMIDA/TIMOLOL STADA 20 mg/ml + 5 mg/ml colirio en solución 1 frasco de 5 ml | Laboratorio Stada S.L. | 12 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | FIXAPROST 50 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASES UNIDOSIS, 30 envases unidosis de 0,2 ml | Laboratoires Thea | 29 Sep 2026 | 5 Nov 2026 | Not stated |
| ES | TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 3 ml | Santen Oy | 27 Oct 2026 | 4 Nov 2026 | Not stated |
| AT | Fixapost 50 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis, 30 Stück | Laboratoires Thea | 18 May 2026 | 31 Jan 2027 | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Duokopt 20 mg/ml + 5 mg/ml Augentropfen, Lösung, 1 Stück | Laboratoires Thea | 22 Jun 2026 | 15 Dec 2026 | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | DorzoComp-Vision sine 20 mg/ml + 5 mg/ml Augentropfen, Lösung, 1 Stück | OmniVision GmbH | 29 Oct 2026 | 21 Dec 2026 | Increased demand Erhöhter Mehrbedarf |
| BE | Kivizidiale 40 µg/ml - 5 mg/ml eye drops sol. dropper cont. 2.5 ml | Bausch + Lomb Ireland | 27 Jan 2025 | 1 Jan 2027 | Manufacturing problem Delay in production |
| BE | Filiop 40 µg/ml - 5 mg/ml eye drops sol. dropper cont. 3 x 2.5 ml | Horus Pharma | 7 Jul 2025 | 31 Dec 2026 | Other Other reason |
| BE | Travoprost/Timolol EG 40 µg/ml - 5 mg/ml eye drops sol. dropper cont. 3 x 2.5 ml | EG | 15 Jun 2026 | 1 Jan 2027 | Manufacturing problem Delay in production |
| BE | Dualkopt 20 mg/ml - 5 mg/ml eye drops sol. dropper cont. 10 ml announced | Laboratoires Théa | 11 Nov 2026 | 28 Dec 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.